Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00900276 · ClinicalTrials.gov registry record
Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 5
- Enrollment target
NCT00900276 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 5 participants.
The verdict
NCT00900276 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood and urine from patients with cancer and from healthy participants in the laboratory may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This laboratory study is looking at biomarkers in patients with kidney cancer or cancer of the urothelium and in healthy participants.
Interventions
- OTHER laboratory biomarker analysis
- OTHER mass spectrometry
- OTHER immunologic technique
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2006-06 |
| Est. Completion | 2011-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00900276
The ClinicalTrials.gov registry entry for NCT00900276 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT00900276 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00900276 about?
NCT00900276 is a clinical study titled "Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants". RATIONALE: Studying samples of blood and urine from patients with cancer and from healthy participants in the laboratory may help doctors identify and learn more about biomarkers related to cancer. PURPOSE: This laboratory study is looking at biomarkers in patients with kidney cancer or cancer of t...
What is the current status of trial NCT00900276?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2006-06. Estimated completion is 2011-04.
What interventions are being tested in trial NCT00900276?
The interventions under investigation include: laboratory biomarker analysis (OTHER), mass spectrometry (OTHER), immunologic technique (OTHER).
Who is sponsoring clinical trial NCT00900276?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.